Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Long Zheng

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Annual Review of Medicine|January 15, 2015
ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpuraX Long Zheng
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
The standard of care for immune thrombotic thrombocytopenic purpura todayX Long Zheng
Journal of Thrombosis and Haemostasis : JTH|February 15, 2024
Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpuraX Long Zheng
Blood|February 27, 2010
ADAMTS13 testing: why bother?X Long Zheng
Annals of Blood|July 25, 2024
Introductory comments about the special series of thrombotic microangiopathyX Long Zheng
Hereditary Genetics : Current Research|May 3, 2014
ADAMTS13, TTP and BeyondX Long Zheng
Blood|January 4, 2014
DNase, ADAMTS13, and iPAD4: good for the heartX Long Zheng
Blood|March 21, 2015
ADAMTS13, lucky to have a hydrophobic pocketX Long Zheng
Expert Review of Hematology|May 16, 2024
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpuraX Long Zheng
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 15, 2025
Restoring VWF multimerization via endothelial gene therapy: A minimalist yet mechanistically precise approachX Long Zheng
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Annual Review of Medicine|January 15, 2015
ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpuraX Long Zheng
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
The standard of care for immune thrombotic thrombocytopenic purpura todayX Long Zheng
Journal of Thrombosis and Haemostasis : JTH|February 15, 2024
Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpuraX Long Zheng
Blood|February 27, 2010
ADAMTS13 testing: why bother?X Long Zheng
Annals of Blood|July 25, 2024
Introductory comments about the special series of thrombotic microangiopathyX Long Zheng
Hereditary Genetics : Current Research|May 3, 2014
ADAMTS13, TTP and BeyondX Long Zheng
Blood|January 4, 2014
DNase, ADAMTS13, and iPAD4: good for the heartX Long Zheng
Blood|March 21, 2015
ADAMTS13, lucky to have a hydrophobic pocketX Long Zheng
Expert Review of Hematology|May 16, 2024
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpuraX Long Zheng
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 15, 2025
Restoring VWF multimerization via endothelial gene therapy: A minimalist yet mechanistically precise approachX Long Zheng
Pageof 15